RTX is converting the European rearmament cycle into reported margin, not just order announcements. Second-quarter operating profit rose 31.0% to $2,811 million on sales of $24,708 million (up 14.5%), lifting the GAAP operating margin to 11.4% from 9.9% a year earlier, while total backlog climbed to $289 billion from $268 billion at year-end. The distinction matters because a defense book-to-bill above 2x is only valuable if the company can also fund the working capital it demands — and here first-half free cash flow rose nearly six-fold to $4.19 billion. For a business where defense programs now sit alongside a commercial aftermarket still absorbing the Pratt & Whitney powder metal disruption, this was the quarter where both engines fired at once.
1. Balance Sheet: Growth Is Being Funded by Customers
1-1. Principal Asset Movements
| Item | Dec 31, 2025 ($M) | Jun 30, 2026 ($M) | Change % |
|---|---|---|---|
| Cash and cash equivalents | 7,435 | 8,305 | +11.7 |
| Accounts receivable, net | 14,701 | 13,942 | -5.2 |
| Contract assets, net | 17,092 | 18,980 | +11.0 |
| Inventory, net | 13,364 | 14,409 | +7.8 |
| Fixed assets, net | 16,868 | 16,965 | +0.6 |
| Goodwill | 53,343 | 52,928 | -0.8 |
| Intangible assets, net | 31,845 | 31,043 | -2.5 |
| Total assets | 171,079 | 173,972 | +1.7 |
The asset side tells a straightforward production-ramp story. Inventory rose $1,045 million and contract assets — revenue recognized ahead of billing — rose $1,888 million, which the company attributes primarily to sales in excess of billings at Pratt & Whitney. Receivables moved the other way, down $759 million, but that decline is not purely a collections win: management discloses that factoring activity added $1.5 billion to operating cash flow versus the prior-year period. Goodwill and intangibles drifted lower on acquisition accounting amortization of $976 million for the half and divestiture effects, with no impairment recorded.
Equity accounts show a company distributing rather than retaining. Retained earnings rose 2.3% to $58,020 million as $4,198 million of attributable net income was offset by $2,882 million of common and ESOP dividends charged during the half. Treasury stock barely moved (from -$26,881 million to -$26,758 million), and the movement was share-based 401(k) matching, not repurchases — there were none. Accumulated other comprehensive loss widened by $591 million to -$3,309 million, driven by foreign currency translation and hedging swings rather than operating results.
Maturity structure is comfortable. Of $37,236 million of principal long-term debt, roughly $10.2 billion (27%) matures through 2029, average maturity is approximately 12 years, and the average interest expense rate ran 4.4% in the quarter. Operating lease right-of-use assets of $1,727 million against $1,473 million of non-current lease liabilities are immaterial to the capital structure.
1-2. Financial vs. Operating Liabilities
Total debt (short-term borrowings $229 million, current portion $5,296 million, long-term $31,858 million) fell to $37,383 million from $37,904 million, and net debt improved to $29,078 million from $30,469 million. Total debt to total capitalization stands at 35%, down from 36%. S&P affirmed BBB+ and revised the outlook to positive in May 2026; Moody's moved Baa1 to positive in February 2026.
Operating liabilities did the heavy lifting for liquidity. Accounts payable rose 6.9% to $16,998 million and contract liabilities — customer advances — rose 4.9% to $22,671 million, together adding roughly $2.2 billion of interest-free funding. Net contract liabilities remain a $3,691 million source of cash, narrower than the $4,523 million at year-end because contract assets grew faster than advances. The $5,296 million of debt due within twelve months is covered 1.6x by cash on hand alone, before an undrawn $5.0 billion revolver.
1-3. Capital Structure
Total equity of $68,116 million includes $38,424 million of common stock (paid-in capital) and $58,020 million of retained earnings, against $26,758 million of treasury stock, with accumulated other comprehensive loss and noncontrolling interests comprising the remainder. Cumulative retained earnings now exceed paid-in capital, which for a company built through the 2020 Raytheon merger and the Rockwell Collins acquisition indicates the combined entity has generated meaningful post-merger earnings rather than living off acquisition accounting.
2. Income Statement: Volume Plus Mix, With a Softer Comparison Base
2-1. Second-Quarter Results
| Item | Q2 2024 ($M) | Q2 2025 ($M) | Q2 2026 ($M) |
|---|---|---|---|
| Net sales | 19,721 | 21,581 | 24,708 |
| Operating profit | 529 | 2,146 | 2,811 |
| Operating margin (%) | 2.7 | 9.9 | 11.4 |
| Net income attributable | 111 | 1,657 | 2,139 |
| Net margin (%) | 0.6 | 7.7 | 8.7 |
| Diluted EPS ($) | — | 1.22 | 1.57 |
Revenue compounded at roughly 10.5% annually from the $18,315 million posted in Q2 2023. The profit series is far noisier, and the reason is disclosed: the first half of 2024 absorbed a $0.9 billion charge for the resolution of certain legal matters and a $0.6 billion Raytheon contract termination charge, while Q2 2025 carried a $0.1 billion Pratt & Whitney charge related to a customer bankruptcy. Normalizing only for that 2025 item, operating profit growth this quarter was closer to 25% than the reported 31%. That is still a strong number, but investors comparing headline profit growth across quarters in this business are largely measuring the absence of prior charges.
Underlying operating leverage was genuine. A 14.5% sales increase produced a 31.0% operating profit increase — a degree of operating leverage of about 2.1x. Gross margin improved to 20.8% from 20.3%, entirely on the products side (17.5% versus 16.5%); services gross margin actually slipped to 29.4% from 30.1%. Fixed-cost absorption did the rest: SG&A rose only 5.4% against 14.5% sales growth, falling to 6.7% of sales from 7.3%, and R&D rose 4.2% to $726 million, or 2.9% of sales versus 3.2%. Under US GAAP all of that R&D is expensed, so this margin is struck on a more conservative basis than an IFRS-reporting European peer that capitalizes development costs.
Below the operating line, net interest expense fell 8.8% to $417 million, but the effective tax rate rose to 18.0% from 15.4% — the prior year included a benefit from the conclusion of an IRS examination of the 2020 tax year. Diluted EPS of $1.57 grew 28.7%, slightly less than the 29.1% net income increase, because the diluted share count edged up to 1,365.0 million from 1,354.0 million. With no buybacks, share creation from equity compensation and 401(k) matching is now a mild dilutive drag rather than an offset.
Net EAC adjustments — cumulative catch-up revisions on long-term contracts — remained negative but improved, cutting operating profit by $66 million versus $117 million a year ago ($228 million versus $275 million for the half). This is the line to watch on fixed-price development work; it is still a headwind, just a shrinking one.
2-2. Segment Mix
| Segment (Q2) | Sales 2025 ($M) | Sales 2026 ($M) | OP 2025 ($M) | OP 2026 ($M) | Margin 2025→2026 (%) |
|---|---|---|---|---|---|
| Collins Aerospace | 7,622 | 8,210 | 1,173 | 1,306 | 15.4 → 15.9 |
| Pratt & Whitney | 7,631 | 8,889 | 492 | 738 | 6.4 → 8.3 |
| Raytheon | 7,001 | 8,269 | 805 | 1,042 | 11.5 → 12.6 |
Pratt & Whitney delivered the largest swing, with operating profit up 50% on a $0.9 billion organic increase in commercial aftermarket sales and $0.4 billion of higher military sales, mostly F135 production volume. Its 8.3% margin remains the group's weakest — the powder metal fleet management plan still runs through the shop network — but the direction has reversed. Raytheon converted an 18.1% sales increase into a 29.4% profit increase on Patriot and Standard Missile volume. Collins was the steadiest and slowest: 7.7% sales growth, with $404 million of divestiture drag masking $981 million of organic growth.
3. Cash Flow: A Real Improvement, Partly Rented
| Item (six months) | 2025 ($M) | 2026 ($M) | Change |
|---|---|---|---|
| Operating cash flow | 1,763 | 5,402 | +3,639 |
| Investing cash flow | (1,187) | (1,552) | -365 |
| Financing cash flow | (1,409) | (2,909) | -1,500 |
| Ending cash | 4,782 | 8,305 | +3,523 |
Free cash flow (operating cash flow less capital expenditures of $1,215 million) came to $4,187 million for the half, against $720 million a year ago and $2,071 million in the same period of 2024 — an 8.9% free cash flow margin. Quality of earnings, measured as operating cash flow divided by net income including noncontrolling interests, was 1.23x, recovering from an unusually weak 0.53x in the first half of 2025 and comparing with 1.69x in 2024.
The caveat is explicit in the filing: factoring of receivables added $1.5 billion to the year-over-year operating cash flow improvement. Strip that out and the underlying gain is roughly $2.1 billion — still substantial, and consistent with the profit increase, but the headline overstates the structural improvement. Working capital also absorbed real cash: contract assets consumed $1,942 million and inventory $1,143 million, offset by a $1,094 million receivable release and $947 million from payables.
Capital expenditure of $1,215 million equals 2.6% of sales, up from 2.5%, with the largest capex levels at Collins ($374 million for the half) and Raytheon ($365 million). This is capacity-supporting spending on a business generating $46.8 billion of half-year revenue, not a step-change investment cycle. Depreciation and amortization of $2,150 million still exceeds capex by a wide margin, though $976 million of that is acquisition accounting amortization rather than economic replacement cost.
Financing outflows widened by $1.5 billion, but almost entirely because the prior year included $1,432 million of commercial paper proceeds. Dividends paid rose 8.5% to $1,898 million; dividends paid per share were $1.41 for the half versus $1.31. Share repurchases were zero, against $50 million a year ago, leaving approximately $0.6 billion of authority under the October 2023 $11 billion program.
4. What Deserves Attention
Backlog and bookings are the real headline. Total backlog reached $289 billion at June 30, 2026, from $268 billion at year-end — commercial $170 billion (from $161 billion) and defense $119 billion (from $107 billion). Defense bookings were approximately $23 billion in the quarter versus $12 billion a year ago, and $37 billion for the half versus $21 billion. Raytheon alone booked $19,898 million against $8,269 million of segment sales, a book-to-bill of 2.4x, including $3.7 billion of Patriot GEM-T interceptors for Ukraine, $988 million of Patriot GEM-T for Poland through the NATO Support and Procurement Agency, $1.1 billion of AIM-9X and $1.1 billion of AMRAAM. Total backlog covers roughly three years of revenue at the current run rate.
Europe is where the growth is. Quarterly sales to Europe rose 27.2% to $5,350 million, now 21.7% of the total, versus 11.6% growth in the United States. Pratt & Whitney's European sales rose 51.1% to $2,325 million and Raytheon's 30.6% to $1,196 million. By customer type, foreign military sales through the U.S. government rose 23.5% to $2,020 million and foreign government direct commercial sales 19.9% to $1,718 million, both outpacing the 12.4% increase in direct U.S. government sales. Government-linked revenue is 52.8% of the total, essentially unchanged from 52.6%, so the commercial and defense engines are growing in step rather than one substituting for the other.
Tariffs are a live but manageable number. RTX has paid approximately $0.5 billion of tariffs in the first half of 2026 under the current administration's trade framework. Management has characterized the impact as largely offset through contract pricing provisions and supply chain adjustments, but the exposure remains a watch item if current policy persists or expands in scope.
This article is based on RTX Corporation's Form 10-Q for the quarter ended June 30, 2026, filed with the U.S. Securities and Exchange Commission. All figures are in U.S. dollars unless otherwise stated. This article is provided for informational purposes only and does not constitute investment advice or a solicitation to buy or sell any security. LineVest News is not a registered investment adviser. Readers should conduct their own due diligence before making any investment decisions.